Our data mirror the generally lower levels of WASp expression within the B-lymphocyte and myeloid compartment compared to T-cells observed in WAS patients treated with the WW1.6 lentiviral vector, and confirm the results obtained in previous clinical11 and pre-clinical studies43. The gene discussed is WAS; the disease is Wiskott-Aldrich syndrome.